Table 4. Linear regression models of boost in SWA-IgE at 9 weeks post-treatment.
Full model | Reduced model | |
β (SE) | β (SE) | |
Sex | −0.174 (0.115) | - |
Village-group | −0.077 (0.125) | - |
Age (v. 5–6 yrs) 7–9 | 0.139 (0.179) | 0.162 (0.175) |
10–14 | 0.207 (0.193) | 0.249 (0.189) |
15–23 | 0.179 (0.212) | 0.245 (0.201) |
24–34 | 0.508 (0.192)** | 0.608 (0.180)** |
35–40 | 0.541 (0.225)* | 0.593 (0.220)** |
log infection intensity | −0.052 (0.032) | - |
log pre-treatment eos no. | 0.036 (0.082) | - |
log 24 hr eotaxin | −0.020 (0.065) | - |
log 24 hr IL-5 | 0.112 (0.047)* | 0.085 (0.040)* |
p<0.05,
p<0.01.